Riskpilot← Back to searchSign inGet full accessEYR MEDICAL AS
ASActiveOrg 915487467Rådhusgata 23, 0158 OsloComputer programming activities · NACE 6210Est. 201516 employeeswww.eyr.md
Revenue 2024
NOK 33,5M
+24% vs 2023
EBITDA margin
-14.0%
+68% vs 2023
Equity ratio
80.1%
Financial strength
Net profit 2024
NOK -6,2M
+64% vs 2023
| Revenue | NOK 33,5M | +24% |
| EBITDA | NOK -4,7M | +68% |
| Net profit | NOK -6,2M | +64% |
| Total assets | NOK 44,2M | -13% |
| Equity | NOK 35,5M | -14% |
| Employees | 16 | — |
Legal name
EYR MEDICAL AS
Org number
915487467
Legal form
Aksjeselskap
NACE code
6210 · Computer programming activities
Founded
5. juni 2015
Share capital
NOK 252 759
Employees
16 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder hver for seg.
Company purpose
Utvikling av applikasjoner og teknologi for bruk innen digital helse og telemedisin. Det kan også bli aktuelt for selskapet å eie andre selskaper, samt gjøre det som naturlig står i forbindelse med det ovennevnte.
Address
Rådhusgata 23, 0158 Oslo
Email
hello@eyr.md
Website
www.eyr.md
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 13 230 | 15 921 | 18 155 | 27 053 | 33 515 |
| Staff expenses | −7 730 | −15 231 | −15 852 | −17 090 | −11 457 |
| EBITDA | −23 713 | −23 924 | −22 829 | −14 679 | −4 703 |
| Depreciation & amort. | −1 112 | −1 131 | −1 131 | −2 511 | −1 665 |
| EBIT | −24 825 | −25 055 | −23 960 | −17 190 | −6 368 |
| Net financials | −589 | −531 | −85 | −20 | 144 |
| Profit before tax | −25 413 | −25 586 | −24 045 | −17 209 | −6 224 |
| Tax | −0 | 56 | −0 | −0 | −0 |
| Net profit | −25 413 | −25 642 | −24 045 | −17 209 | −6 224 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 38 638 | 55 100 | 30 761 | 50 732 | 44 240 |
| Equity | 24 801 | 43 711 | 19 537 | 41 243 | 35 453 |
| Long-term debt | 5 000 | 1 500 | 1 500 | 0 | 0 |
| Short-term debt | 8 837 | 9 890 | 9 723 | 9 489 | 8 787 |
| Total debt | 13 837 | 11 390 | 11 223 | 9 489 | 8 787 |
EBITDA margin
-14.0%
This company
15.8%
Market median
-189% vs market
20202024
Equity ratio
80.1%
This company
38.2%
Market median
+110% vs market
20202024
Return on equity
-17.6%
This company
18.4%
Market median
-196% vs market
20202024
Net profit margin
-18.6%
This company
8.1%
Market median
-330% vs market
20202024
Asset turnover
0.76×
This company
1.12×
Market median
-32% vs market
20202024
Debt / equity
0.25×
This company
0.62×
Market median
+60% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
TR Observer | Observer | 2024 |
KS Chief Executive Officer | Chief Executive Officer | 2025 |
| Former (4) | ||
CK Chief Executive Officer | Chief Executive Officer | 2021 – 2022 |
PH Chief Executive Officer | Chief Executive Officer | 2024 – 2025 |
PS Observer | Observer | 2023 – 2024 |
TB Observer | Observer | 2024 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2021 | |
| Chairman | 2025 | |
| Board of Directors | 2025 | |
| Former (2) | ||
| Chairman | 2021 – 2021 | |
| Board of Directors | 2021 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 26.57% | 26.57% | 2024 | |
| Company | 16.35% | 16.35% | 2024 | |
Fros Ventures Ab | Company | 11.9% | 11.9% | 2024 |
| Individual | 11.66% | 11.66% | 2023 | |
| Individual | 9.73% | 9.73% | 2024 | |
Elk Street Capital Ab | Company | 6.66% | 6.66% | 2024 |
| Individual | 4.84% | 4.84% | 2022 | |
| Company | 4.42% | 4.42% | 2024 | |
| Company | 3.9% | 3.9% | 2024 | |
Frtroligheten Film Ab | Company | 3.3% | 3.3% | 2024 |
| Company | 2.6% | 2.6% | 2024 | |
| Company | 2.13% | 2.13% | 2024 | |
Fredrik Svederman | Company | 1.74% | 1.74% | 2024 |
| Company | 1.74% | 1.74% | 2024 | |
| Company | 1.33% | 1.33% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of EYR MEDICAL AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Camilla Kluge Foss | Chief Executive Officer | 0 companies |
| Poul Heinrich Koza | Chief Executive Officer | 0 companies |
| Torjus Randeberg Falkanger | Observer | 0 companies |
| Pål Sommer Breiland | Observer | 0 companies |
| Torjus Bertheussen Falkanger | Observer | 0 companies |
| Kine Skjervum-Karlsen | Chief Executive Officer | 0 companies |
| Ole Johan Gillebo | Chairman | 0 companies |
| Patrick Sandahl | Board of Directors | 0 companies |
| Susan Elizabeth Hagerty Bonsak | Chairman | 0 companies |
| Vegard Krogh-Reinsnes | Board of Directors | 0 companies |
| Axel Dahl | Board of Directors | 0 companies |